GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc ('GSK') was advised on 9 June 2015 of the following increase in the notional allocation of GSK American Depositary Shares ('ADSs') on 8 June 2015, at a price of $42.24 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:
Connected person |
Number of ADSs |
Dr K Slaoui (connected person of Dr M Slaoui) |
5 |
V A Whyte
Company Secretary
9 June 2015